Trial intelligence / Profile preview

Lidocaine, Cold Packs, and Flash Lights for Cannulation Pain

NCT05822063Phase 3Unknown

Sponsor
Ain Shams University
Start
Jul 2023
Primary completion
Aug 2023
Modality
Small Molecules
01

Overview

Phase 3, randomised, open-label trial of lidocaine 10% oropharyngeal spray in procedural pain (4 arms), sponsored by Ain Shams University. Primary endpoint: Visual Analogue Scale at 1 month. Status: unknown.

02

Drugs

lidocaine 10% oropharyngeal spray
03

Conditions

procedural pain

Beyond the preview

Go deeper on NCT05822063.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05822063.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call